EL
Industry & Hardware
Elegen
United Stateselegenbio.com/
Elegen is an Industry & Hardware startup based in the United States, most recent round Series B, 1 tracked investor.
Activeseries-b
series-b
Stage
1
Investors
About Elegen
Elegen is a company headquartered in the United States. Its most recent tracked round is Series B. Brouky classifies it under Industry & Hardware. Brouky records 1 investor associated with the company.
Elegen develops a proprietary cell-free DNA synthesis platform called ENFINIA™, which uses microfluidics, AI, and robotics to produce long, high-quality, clonal linear DNA rapidly and cost-effectively without cloning or cells.
Explore Elegen's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.